Blog

– Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients –

– Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease –

Data discussion webcast/conference call will be held at 8:30 am Eastern Time

SAN DIEGO, CA / ACCESS Newswire / September 10, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing inflammation, will host a corporate update webcast/conference call (details below) at 8:30 am Eastern Time to review groundbreaking activity data from its Phase 1b PRIME clinical study in stage 3 and 4 chronic kidney disease (CKD) patients. The primary endpoint to evaluate the safety and tolerability of escalating doses of Gemini was met.

More importantly, Gemini significantly reduced inflammatory activity and restored normal cellular response to stimuli as measured in peripheral blood mononuclear cells (PBMCs) isolated from patients at predose, 2, 24, and 168 hours post-dose, demonstrating Gemini’s ability to durably rebalance the inflammatory process at the cellular level.

“The activity observed with a single dose of Gemini in patients is shocking,” said Principal Investigator Adam Horeish, MD, Balboa Research. “This effect suggests a meaningful step forward in addressing the underlying immune dysregulation observed in patients with chronic kidney disease, and I am intrigued by the potential of Gemini to treat multiple types of acute and chronic inflammation.”

“The results from this Phase 1b study represent a possible breakthrough in the treatment of inflammation,” said Principal Investigator Pablo Pergola, MD, PhD,Research Director at Clinical Advancement Center, PLLC. “By addressing the inflammatory component of CKD, we may be able to improve patient outcomes and bring meaningful benefit to those living with this challenging condition. We look forward to working with the Revelation team to advance Gemini as a potential treatment for CKD.”

“The clear results from the PRIME study demonstrate the power of Gemini to elicit trained immunity,” said Julia K. Bohannon, Ph.D., Associate Professor, Department of Anesthesiology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center. “It is highly validating to see results consistent with the findings from our animal studies, as I would have expected. The strength of the effect of a single dose reinforces my confidence in the potential of Gemini as a promising treatment for burn patients.”

The PRIME study enrolled 40 patients from 32 to 78 years of age, at 3 US clinics located in San Diego and San Antonio, specializing in the care of patients with CKD. A total of 5 cohorts (8 patients per cohort, 6 treated/2 placebo) at 4 dose levels were enrolled: a subtherapeutic dose, a low dose, the target dose (cohorts 3 and 4), and a high dose – an extension protocol was conducted to collect additional PBMC and biomarker samples in 8 Gemini naive or secondary naive patients. The primary endpoint was evaluation of safety.

In addition to safety measures, patient PBMCs were isolated predose and at 2, 24, and 168 hours post-dose. PBMCs were analyzed ex vivo for background inflammation by measurement of IL-1β, TNF-α, IL-6, IL-10, and IL-1RA. Cells were also assessed for response to stimulation by lipopolysaccharide (LPS, also known as endotoxin) or high mobility group box-1 protein (HMGB1). Subgroup analysis divided patients into two categories, those with PBMCs of minimal background inflammation activity (£40 pg/mL IL-1β) and normal response to stimuli, and those with significant background inflammation activity (>40 pg/mL IL-1β) and no response to stimuli. Approximately 50% of patients were in each group.

In patients with high background PBMC activity, Gemini significantly reduced inflammation relative to placebo patient PBMCs post dose (IL-1β: p0.01; TNF-α: p=0.05; IL-6: p0.01; IL-10: p0.01; IL-1RA: p0.001) and remained significantly below their baseline value through 7 days. Background inflammation was reduced to levels comparable to PBMCs isolated from healthy subjects.

Additionally, Gemini was able to demonstrate correction of the immunoparalysis typical to chronic disease. Gemini significantly increased the responsiveness to LPS stimulation in high background patient PBMCs relative to placebo at all timepoints (IL-1β: p0.0001; TNF-α: p0.002; IL-6: p0.0002; IL-10: p=0.09; IL-1RA: p0.01). Gemini also significantly increased the responsiveness of patient PBMCs with high background vs placebo patient PBMCs with high background at all time-points to HMGB1 stimulation (IL-1β: p0.05; TNF-α: p0.01; IL-6: p0.01; IL-10: p0.05; IL-1RA: p0.002). The increased responsiveness was comparable to PBMCs isolated from healthy subjects. These results show the ability of Gemini to restore normal cell function, even as far as one week after a single dose.

For the low background patients, as expected, Gemini does not increase inflammatory activity. Additional analysis on the effect of LPS or HMGB-1 stimulation is ongoing.

Gemini administration was well-tolerated at the target dose (established as the maximum tolerated dose in healthy volunteers) with all events reported as mild (Grade I). Adverse events observed at the target dose included transient headache, chills, loose stool, and body aches. Three adverse events at the highest dose (above the target dose) were reported as severe (Grade III), and included chills, nausea and vomiting, all resolving in 3 hours or less. Other reported events were either mild (Grade I) or moderate (Grade II). All events corresponded with the previous healthy volunteer study, as well as with preclinical findings, and are consistent with the expected pharmacology of the drug. No serious adverse events were reported. Gemini administration did not result in clinically significant trends in clinical safety blood or urinalysis parameters (aside from expected immune cell mobilization). There were no clinically significant changes or trends in vital sign parameters or ECG assessments following administration of Gemini.

“The results of the PRIME study demonstrate the potential of Gemini to be a game-changer in the treatment of acute and chronic inflammation,” said James Rolke, Chief Executive Officer of Revelation. “We look forward to our scheduled End of Phase 1 meeting with the FDA later this year to discuss the advancement of this exciting program.”

The webcast at 8:30 am Eastern Time can be accessed https://www.webcaster4.com/Webcast/Page/3139/52906, or to call in, please dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use participant access code 289672. A copy of the slides being presented in the webcast can be found on Revelation’s website https://www.revbiosciences.com/s/925P1bData.pdf.

Revelation will seek to publish these results and those from ongoing additional data analysis. For more information, please visit www.RevBiosciences.com.

About CKD

Chronic kidney disease is a pervasive problem in the United States and world-wide. CKD is due to chronic inflammation and can be initiated and propagated in several ways. One prevalent condition is the high blood sugar levels associated with diabetes (either Type 1 or Type 2). High blood sugar is toxic to kidney cells creating stress which imitates the inflammatory process leading to the demise of these cells with subsequent fibrosis, ultimately resulting in continuous loss of kidney function over time. High arterial blood pressure is another source of stress that initiates the inflammatory process leading to CKD. Other risk factors include heart disease, obesity, family history of CKD, or advanced age. Progression of chronic kidney damage often leads to end stage renal disease with the need for renal replacement therapy (dialysis or transplantation), resulting in significant morbidity and mortality for affected patients. Kidney disease is a leading cause of death in the United States.

About Gemini

Gemini is the Company’s proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD^®), a toll-like receptor 4 (TLR4) agonist. TLR4 stimulation with Gemini rebalances the innate immune response. Gemini is being developed as a treatment and a prevention of acute and chronic diseases associated with dysregulated inflammation.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and for the treatment of chronic kidney disease.

For more information, please visit www.RevBiosciences.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions. We caution investors that forward-looking statements are based on management’s expectations and are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by the forward-looking statements. Revelation cautions readers not to place undue reliance on any such forward looking statements, which speak only as of the date they were made. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: the ability of Revelation to meet its financial and strategic goals, due to, among other things, competition; the ability of Revelation to grow and manage growth profitability and retain its key employees; the possibility that the Revelation may be adversely affected by other economic, business, and/or competitive factors; risks relating to the successful development of Revelation’s product candidates; the ability to successfully complete planned clinical studies of its product candidates; the risk that we may not fully enroll our clinical studies or enrollment will take longer than expected; risks relating to the occurrence of adverse safety events and/or unexpected concerns that may arise from data or analysis from our clinical studies; changes in applicable laws or regulations; expected initiation of the clinical studies, the timing of clinical data; the outcome of the clinical data, including whether the results of such study is positive or whether it can be replicated; the outcome of data collected, including whether the results of such data and/or correlation can be replicated; the timing, costs, conduct and outcome of our other clinical studies; the anticipated treatment of future clinical data by the FDA, the EMA or other regulatory authorities, including whether such data will be sufficient for approval; the success of future development activities for its product candidates; potential indications for which product candidates may be developed; the ability of Revelation to maintain the listing of its securities on NASDAQ; the expected duration over which Revelation’s balances will fund its operations; and other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the SEC by Revelation.

Company Contact

Mike Porter
Investor Relations
Porter LaVay & Rose Inc.
Email: mike@plrinvest.com

Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: czygmont@revbiosciences.com

SOURCE: Revelation Biosciences, Inc.

View the original press release on ACCESS Newswire

MONTREAL, QC / ACCESS Newswire / September 10, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR) (“Vision Marine” or the “Company”), a pioneer in electric marine propulsion with an award-winning retail network, Nautical Ventures, today announced the advancement of its Electric Representative Training Program across Nautical Ventures’ Florida dealership network.

The program has completed its first phase with the selection and training of Electric Representatives at strategic locations. Customers visiting Nautical Ventures showrooms now receive informed guidance on Vision Marine’s proprietary E-Motion^™ 180E, the industry’s first certified 180 HP continuous electric outboard, engineered for performance, reliability, and seamless integration across multiple boat platforms. Vision Marine has already delivered two E-Motion^™ 180E-equipped boats to customers and finalized additional integrations scheduled for delivery in the coming month. These initial deliveries demonstrate that production is active and that Vision Marine is already placing boats into customer hands, while preparing dealerships to guide and support adoption as more integrations follow.

The next phase of the program expands into on-water training sessions, giving sales staff hands-on rundowns of electric powertrain operation and performance. In the coming weeks, E-Motion^™ 180E-equipped boats will also be made available for demonstrations, ensuring teams can share firsthand experience with prospective customers. The program highlights the advantages of Vision Marine’s electric powertrain, including significant noise reduction, the absence of gasoline fumes, reduced maintenance requirements, and strong torque delivery compared to internal combustion engines.

“Education is essential for adoption,” said Alexandre Mongeon, CEO of Vision Marine. “By combining structured training with real-world demonstrations, we ensure our teams are confident in presenting the full potential of E-Motion^™ technology, from its unmatched 180 HP continuous output to its proven integration across boat models. At the same time, our recent deliveries highlight that production is commercial boats are being delivered and enjoyed on the water.”

Nautical Ventures Group now has multiple Vision electric boats in stock at its east and west coast showrooms, available for immediate delivery. This rollout underscores Vision Marine’s broader strategy of integrating electric propulsion responsibly within an award-winning retail network, while anchoring adoption on the Company’s industrialized E-Motion^™ 180E platform.

About Vision Marine Technologies Inc.

Vision Marine Technologies Inc. (NASDAQ:VMAR) is a disruptive marine company offering premium boating experiences across both electric and internal combustion segments. Through its E-Motion^™ high-voltage technology and Nautical Ventures’ nine-location retail and service network in Florida, Vision Marine unites proprietary engineering with direct-to-consumer sales, after-sales support, and integration services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could cause such differences include, among others, market conditions, customer adoption, operational execution, and regulatory developments. Vision Marine undertakes no obligation to update forward-looking statements except as required by law.

Investor Relations Contact:

Bruce Nurse
Vision Marine Technologies Inc.
(303) 919-2913
bn@v-mti.com

SOURCE: Vision Marine Technologies Inc

View the original press release on ACCESS Newswire

Maxon One unifies Cinema 4D, ZBrush, Redshift, and Red Giant in bold ecosystem redesign, with tons of new feature capabilities across VFX, 3D modeling, and motion graphics solutions.

BAD HOMBURG, GERMANY / ACCESS Newswire / September 10, 2025 / Maxon today unveiled the latest Maxon One release, delivering new innovations across its unified creative ecosystem and introducing a fresh visual identity that is modular, cohesive, and connected. Designed to empower artists at every skill level, from students to seasoned industry veterans, the Fall release streamlines workflows, removes technical barriers, and delivers cutting-edge creative possibilities across VFX, motion graphics, 3D modeling, sculpting, rendering, editing, and more.

From cinematic storytelling to broadcast graphics, gaming design to architectural visualization, creators across the full spectrum of disciplines rely on Maxon One for its deeply integrated tools. Cinema 4D now has GPU-accelerated art-directable simulations, while Maxon Studio streamlines video and broadcast design with Red Giant effects and customizable templates, enhanced with embedded assets and reusable Capsules. Redshift pushes architectural rendering to new heights with procedural clouds, refined realism, and faster interactive displacement, while ZBrush brings professional-grade sculpting to iPad with 3D printing support and powerful pipeline integration. This release expands on the power of Maxon’s capabilities, all within a unified platform that moves ideas seamlessly from concept to final render.

“Maxon One is the creative backbone for artists across industries and at all skill levels,” said David McGavran, CEO of Maxon. “This release builds on the features creators already love while introducing innovations that remove technical barriers and open new creative possibilities. Whether you’re in the classroom or at the helm of a major production, Maxon One helps you create without limits.”

A Unified Ecosystem for Every Stage of Creation

The Maxon ecosystem is built on innovations that empower creative freedom, from the portability and precision of ZBrush on iPad to the immersive visual fidelity and cinematic quality of Redshift rendering. Maxon One unifies Cinema 4D, ZBrush, Redshift, Red Giant, and Maxon Studio in a deeply integrated platform designed to work harmoniously from one stage of creation to the next. With compatibility across industry-leading tools such as Adobe Creative Cloud and Blackmagic Design, creators can build, animate, render, and finish their projects without friction.

New Maxon Capabilities Across Every Creative Discipline

For animators and motion graphics designers, Cinema 4D enables fast, unified simulations that are easy to create and art-direct. All the procedural power of C4D integrates seamlessly with rigid-body, soft-body, cloth, pyro, particles, and now liquids. The new AI search, which operates entirely on your local machine, makes finding Capsules, assets, textures, and presets effortless, with faster and more precise results ready in an instant.

For game developers and virtual production teams, the latest Cineware for Unreal Engine streamlines asset, lighting, and material workflows, reducing rework and accelerating iteration. Support for Cinema 4D modifiers, enhanced texture tag controls, and automatic material instance creation keep scenes accurate and flexible from import to final output, empowering teams to focus on worldbuilding, not pipeline roadblocks.

For sculptors and 3D modelers, ZBrush adds creative freedom on desktop and iPad. Python scripting, available on desktop, unlocks automation and deeper pipeline integration, while 3D printing tools bring full desktop parity to the iPad. Surface Noise also sees an upgrade with a refreshed UI, per-noise resets, alpha transforms, and full undo/redo support, giving artists greater control over detail. ZBrush for iPad UI enhancements let users move the bottom bar, adjust the modifier wheel, and save or share custom interfaces for a personalized setup. Artists can rapidly sculpt, customize, and export designs for collectibles, props, and prototypes, with upcoming UV editing and hard-surface modeling updates extending its versatility.

For VFX artists, Redshift introduces new tools for photorealistic and stylized environments with greater realism and speed. Texture Displacement delivers faster, interactive previews with minimal subdivision; Scene Units ensure materials match real-world scale; and the new Procedural Clouds and Sun & Sky system make it effortless to add atmospheric depth to any scene. Artists can render more accurate, visually rich worlds in less time, whether for film, advertising, or immersive media.

For editors and colorists, Maxon Studio now supports embedded assets and reusable Capsules, making it possible to build once and use anywhere. This means more customization, faster setup, simple scaling, and consistent brand visuals, all without leaving the creative environment.

“For my new film ‘SKETCH’ (out now in theaters!), we sculpted creatures in ZBrush, animated in Cinema 4D, rendered in Redshift, and polished with Red Giant, all without ever feeling like we were duct-taping workflows together. Every production throws curveballs, but knowing exactly how I could ‘fix it in post’ with Maxon tools eliminated many of the usual roadblocks that inevitably come up when you’re creating 11+ monsters made out of glitter, chalk and crayons,” said Seth Worley, Director of “SKETCH” (read more about how Seth and team brought the film’s monsters and effects to life). “I think I can say definitively that, without Maxon One, we would still be finishing the movie.”

Trusted by the World’s Leading Creatives
Maxon One powers work for leading artists and studios worldwide, producing content that captivates audiences across every medium. From blockbuster films and award-winning streaming series to AAA games and global ad campaigns, Maxon’s tools deliver quality, efficiency, and creative freedom. Recent projects include:

• Godzilla Minus One: Director Takashi Yamazaki and Modeler Kousuke Taguchi used ZBrush to reimagine the iconic monster, utilizing Redshift for rendering with speed and high-fidelity.

• Shōgun: Winning 2024 Creative Arts Emmy® Award for Outstanding Main Title Design, design studio Elastic brought the Shōgun title sequence to life entirely in Cinema 4D, with key props like the samurai helmet meticulously crafted in ZBrush to match existing assets from the show.

• God of War: Ragnarök: U.K.-based freelance creature designer and digital sculptor Luke Starkie used ZBrush to sculpt creatures, including one of the most memorable bosses for PlayStation’s flagship title.

• Tuft & Needle: ManvsMachine relied on Cinema 4D and Redshift to help retailer Tuft & Needle visualize what it takes to create the elements of a perfect night’s sleep.

Committed to the Next Generation: Dream It. Make it.

Every great artist starts with curiosity and a spark of imagination. That’s why Maxon is making it easier than ever for students, hobbyists, and emerging creators to jump in and start creating. From free tutorials and global community events to affordable student licenses for the same tools used on blockbuster films and AAA games, Maxon gives creators everything they need to learn, experiment, and grow. Whether you’re crafting your first 3D scene, sculpting characters on an iPad, or exploring motion graphics for social content, Maxon is here to help artists turn ideas into something amazing.

Experience Maxon One at IBC2025

Attendees can experience the new Maxon One release and its reimagined ecosystem at IBC2025, RAI Amsterdam, September 12-15. Visit Booth 7.B45 to see live demos of procedural animation in Cinema 4D, real-time rendering in Redshift, mobile sculpting in ZBrush, and streamlined design-to-delivery workflows in Red Giant and Maxon Studio.

Book a meeting or training session with Maxon experts to learn more about Maxon One, or a specialized training session with experts to learn more about:

• Cinema 4D

• Red Giant

• Redshift

• ZBrush

About Maxon

Maxon is a developer of high-quality, professional creative tools that empower artists to bring stunning visuals to life. From 3D modeling and animation to impeccable rendering and cinematic effects, the Maxon One ecosystem provides a comprehensive suite of industry-leading solutions. At Maxon, we are committed to fueling creative freedom, fostering a thriving artistic community, and being the driving force behind bold, iconic content.

Media Contact

Megan Fasy
Grithaus Agency
(e) megan@grithaus.agency
(p) +1 (617) 480-3674

###

SOURCE: Maxon Computers

View the original press release on ACCESS Newswire

SAN BERNARDINO COUNTY, CA / ACCESS Newswire / September 10, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) (Dateline or the Company), a North American-focused mining and exploration company, is pleased to announce that it has commenced a major drilling campaign at its 100%-owned Colosseum Gold-REE Project in San Bernardino County, California.

Highlights

• Drilling Underway – Drilling has commenced this week at the 100%-owned Colosseum Gold-REE Project in California.

• Expanded Drill Fleet – Major Drilling has been contracted to provide a high-powered, fast reverse circulation (RC) rig, supplementing Dateline’s fleet of three company-owned drill rigs (two currently on site) and significantly boosting drilling speed and capacity.

• Large-Scale Campaign – The total drilling program is expected to exceed 10,000 metres of combined RC and diamond drilling, with activities anticipated to continue through the remainder of 2025.

• New Gold & REE Targets -Recently identified magneto-telluric (MT) generated gold and rare earth element targets are being refined and will be progressively incorporated into the drilling plan. These include multiple high-priority gold targets (breccia pipe anomalies) and deep REE targets identified by geophysical surveys.

• Geotechnical Program – A dedicated geotechnical drilling program is underway in parallel, gathering critical data to inform mine planning and support BFS-level engineering studies.

• Accelerating BFS – The program will accelerate the Colosseum BFS, with drilling data to support mine design and resource upgrades aimed at expediting the timeline to first gold production.

Drilling started this week and will include extensional gold drilling around the existing 1.1 Moz gold resource, as well as testing new regional targets. This campaign represents a pivotal step in advancing the Bankable Feasibility Study (BFS) and is aimed at accelerating Colosseum’s development toward near-term gold production.

To maximise efficiency and drilling throughput, Dateline is augmenting its on-site drill fleet. While the Company currently has two owned drill rigs at Colosseum, it has opted to deploy one of its own diamond drill rigs and supplement it with a high-performance reverse circulation (RC) rig provided by Major Drilling, the world’s leading provider of specialized drilling services in the metals and mining industry.

The contracted RC rig is being mobilised to site in the next 1-2 weeks and offers faster drilling rates, allowing the Company to rapidly progress both mineral resource-definition drilling and exploration of new targets in tandem. In addition to mineral resource drilling, a geotechnical drilling program has commenced, which will collect essential data on rock stability and ground conditions to feed into mine design and planning for the BFS.

The drilling plan will also progressively test several new exploration targets for gold and rare earths. These targets have been generated from recent exploration datasets, including a 3D magneto-telluric (MT) geophysical survey and detailed geochemical and mapping programs. Notably, the Company has identified six high-priority gold target areas (interpreted as potential breccia pipe structures) exhibiting similar geophysical signatures to the known gold-bearing pipes at Colosseum.

Additionally, multiple deep-seated resistivity anomalies pointing to possible carbonatite-hosted REE mineralisation (analogous to the nearby Mountain Pass mine) have been delineated. Ongoing analysis of the MT and geochemical results is refining these targets, which will be added to the drill schedule as they are confirmed and ranked. By pursuing gold and REE exploration in parallel, Dateline aims to unlock Colosseum’s dual commodity potential efficiently and enhance the project’s overall economics.

The total drilling program is expected to exceed 10,000 metres of RC and diamond drilling. This extensive campaign, one of the largest undertaken at Colosseum, is scheduled to run through at least the end of 2025. Drilling results will be reported as they become available and will feed directly into the Colosseum BFS workstreams, including a potential updated Mineral Resource estimate and open-pit mine designs.

Dateline’s Managing Director, Stephen Baghdadi, commented:

“This is an exciting phase for Dateline as we kick off a major drill program at Colosseum, which is instrumental in accelerating our feasibility study and bringing us closer to production. By utilizing our in-house diamond rig alongside Major Drilling’s high-powered RC rig, we can significantly increase the pace and scope of drilling, allowing us to tackle mineral resource infill, extensional drilling, and new target testing all at once.

“The ability to drill more metres faster will fast-track the Colosseum BFS and shorten the timeline to first gold production. We’re also eager to drill the newly identified gold and rare earth targets, which have the potential to add substantial value.“

Figure 1: Plan view of Colosseum with areas to initially be targeted in the drilling program

Figure 2: Diamond drilling underway at Colosseum

About Dateline Resources Limited

Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) is an Australian publicly listed company focused on high-value mining and exploration in North America. Its flagship Colosseum Gold-REE Project in California’s Walker Lane Trend combines a proven gold resource with emerging rare earth potential, positioning Dateline as a leader in critical minerals and precious metals.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or performance, including the potential of the Colosseum Project, the benefits of U.S. government support, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on current expectations, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include fluctuations in gold and rare earth element prices, changes in regulatory or permitting processes, geological or technical challenges, market conditions affecting capital raising, environmental or social factors, and risks related to securing government funding. Dateline Resources cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The company undertakes no obligation to update or revise these statements, except as required by law.

Contact Information

Stephen Baghdadi
Managing Director
Dateline Resources Limited
+61 2 9375 2353
info@datelineresources.com.au
www.datelineresources.com.au

Andrew Rowell
Corporate & Investor Relations Manager
a.rowell@dtraux.com
+61 400 466 226

Follow Dateline on social media:

X: @Dateline_DTR
Truth Social: @dateline_resources
LinkedIn: dateline-resources

This press release is authorized for release by the Board of Dateline Resources Limited.

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

CALGARY, ALBERTA / ACCESS Newswire / September 10, 2025 / Calgary Integrative Medicine, a leading provider of holistic healthcare in the city, has been honoured with the 2025 Consumer Choice Award in the naturopathic medicine category for Southern Alberta. This recognition marks the clinic’s sixth consecutive year as a recipient, underscoring its commitment to delivering exceptional, patient-centred care.

Since opening in 2017, Calgary Integrative Medicine has established itself as a trusted destination for individuals seeking natural solutions to their health concerns. The clinic is known for its personalised approach to care, tailoring treatments to the specific needs of each patient. With a focus on chronic disease, digestive health, pain management, healthy ageing, and cancer care support, its naturopathic doctors combine traditional practices with innovative therapies to help patients restore balance and improve quality of life.

Comprehensive Services That Support Healing

The clinic offers a wide range of therapies designed to support the body’s natural ability to heal. Patients can access IV nutritional therapy, acupuncture, and herbal remedies, as well as lifestyle and nutritional counselling. These services are complemented by advanced options such as cancer care support, injection therapies, and manual osteopathy, ensuring that each treatment plan is evidence-informed and results-focused.

“Our philosophy is simple,” says Dr. Greg Sikorski, B.Sc., N.D., Clinic Owner. “We believe every patient deserves care that is tailored to them. By combining the latest in natural therapies with specialised services such as cancer care support and injection therapies, we empower people to take control of their health and feel their best.”

This blend of natural treatments and advanced therapies has made the clinic a go-to destination for individuals looking for long-term solutions to health challenges rather than temporary fixes. Whether managing a chronic condition or pursuing preventative care, patients find comprehensive support in a welcoming, patient-first environment.

A Celebration of Patient Confidence

Winning the Consumer Choice Award for six consecutive years reflects not only clinical excellence but also the confidence and loyalty of the Calgary community. The award is based on independent research that evaluates brand reputation, consumer satisfaction, and business performance in local markets. For Calgary Integrative Medicine, this recognition is a powerful reminder of the trust patients place in its doctors and staff.

“We are truly honoured to receive this recognition again,” adds Dr. Sikorski. “The feedback and trust of our patients inspire us to continue raising the standard of care. This acknowledgement motivates our entire team to keep innovating and providing therapies that genuinely improve people’s lives.”

Building Lasting Relationships with Patients

Calgary Integrative Medicine’s success stems from its patient-focused philosophy. Rather than offering one-size-fits-all solutions, practitioners take the time to understand each individual’s health history, lifestyle, and goals. By building strong relationships and focusing on root causes, the clinic helps patients achieve lasting results.

This approach resonates with Calgarians who are seeking more than conventional treatments alone. With its emphasis on whole-person health, Calgary Integrative Medicine continues to attract individuals from across Southern Alberta who are eager to explore natural, integrative healthcare.

A Trusted Wellness Partner for Calgary

Beyond clinical services, the clinic is dedicated to promoting wellness across the community. By raising awareness about the benefits of naturopathic medicine and encouraging preventative health practices, Calgary Integrative Medicine plays a key role in shaping healthier lifestyles. Its growth and ongoing recognition are a testament to its positive impact on both patients and the wider community.

As healthcare continues to evolve, the clinic remains committed to advancing its services while staying true to its core values of compassion, integrity, and personalisation. With a team of dedicated naturopathic doctors and a proven track record of patient satisfaction, Calgary Integrative Medicine is well-positioned to continue leading the way in natural and integrative healthcare in Southern Alberta.

To learn more about Calgary Integrative Medicine or to book an appointment, visit www.calgaryintegrativemedicine.ca or CLICK HERE.

About Calgary Integrative Medicine
Founded in 2017, Calgary Integrative Medicine is a leading naturopathic clinic in Calgary, Alberta. Specialising in chronic disease, digestive health, pain management, healthy ageing, and cancer care support, the clinic combines traditional and innovative therapies to promote lasting health. Services include IV nutritional therapy, acupuncture, herbal medicine, injection therapies, and manual osteopathy. With a focus on personalised care, Calgary Integrative Medicine empowers patients to restore balance and achieve long-term wellness. Learn more at www.calgaryintegrativemedicine.ca.

About Consumer Choice Award
Since 1987, Consumer Choice Award has been recognising and promoting business excellence across North America. Through a rigorous selection process, only the most outstanding businesses in each category earn this prestigious recognition. Learn more at www.ccaward.com.

Contact Information
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

CALGARY, AB / ACCESS Newswire / September 10, 2025 / Yanko Popovic Sidhu, a trusted leader in personal injury law, has been recognised with the 2025 Consumer Choice Award in the Lawyer – Personal Injury category for Southern Alberta. This recognition highlights the firm’s long-standing reputation for trust, integrity, and results in representing victims of personal injury with dedication and compassion.

With decades of combined legal expertise, Yanko Popovic Sidhu has built a practice centred on advocating for clients during some of life’s most difficult moments. The firm’s mission goes beyond legal representation-it is about offering clarity, guidance, and unwavering support to help injury victims and their families navigate the complexities of the legal system.

Dedicated To Client Advocacy

Personal injury cases often come with uncertainty and emotional stress. The legal professionals at Yanko Popovic Sidhu are committed to easing that burden, ensuring clients feel heard, supported, and protected throughout the process.

“Our clients put their trust in us during incredibly challenging times,” says the Yanko Popovic Sidhu team. “Being recognised with the Consumer Choice Award is especially meaningful because it reflects the confidence and appreciation of the people we serve.”

Recognition That Reflects Community Trust

The Consumer Choice Award is determined through independent research that measures brand reputation, client satisfaction, and business excellence. For Yanko Popovic Sidhu, being selected as Southern Alberta’s top personal injury law firm reaffirms its commitment to standing by clients and delivering results that matter.

“This recognition is not just about legal expertise-it’s about the trust we’ve built,” the team adds. “Every case is an opportunity to stand up for someone’s rights and make a real difference in their life.”

Experience That Delivers Results

Over the years, Yanko Popovic Sidhu has represented a wide range of personal injury victims, from those injured in motor vehicle accidents to individuals impacted by workplace injuries and other life-altering events. The firm’s success is rooted in a balance of legal expertise, strategic advocacy, and a compassionate approach that recognises the human impact behind every case.

By focusing on both outcomes and the client experience, Yanko Popovic Sidhu continues to be a trusted choice for personal injury representation across Southern Alberta.

A Commitment to Justice and Care

As the firm celebrates its 2025 Consumer Choice Award recognition, Yanko Popovic Sidhu remains dedicated to upholding the values that have guided its work for decades: integrity, advocacy, and care for clients. With every case, the team strives to provide peace of mind and justice for those navigating the aftermath of personal injury.

To learn more about Yanko Popovic Sidhu or to schedule a consultation, visit www.yanko.ca or CLICK HERE.

About Yanko Popovic Sidhu
Yanko Popovic Sidhu is a Calgary-based law firm dedicated to advocating for personal injury victims across Southern Alberta. With decades of experience and a proven track record of results, the firm is committed to providing clear guidance, compassionate support, and strong representation. Its practice areas include motor vehicle accidents, workplace injuries, and other personal injury claims. Learn more at www.yanko.ca.

About Consumer Choice Award
Since 1987, Consumer Choice Award has been recognising and promoting business excellence across North America. Through a rigorous selection process, only the most outstanding businesses in each category earn this prestigious recognition. Learn more at www.ccaward.com.

Contact Information
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

Uber accelerates incident detection, DCAI speeds up AI training and cluster efficiency, and Nebius improves MTBF in large-scale distributed AI training-all powered by Clockwork’s first-of-a-kind Software-Driven-Fabric.

PALO ALTO, CA / ACCESS Newswire / September 10, 2025 / Clockwork, the company redefining how enterprises run large-scale AI infrastructure, today announced FleetIQ, a first-of-its-kind Software-Driven Fabric (SDF) built to maximize GPU utilization, accelerate AI job performance, increase infrastructure reliability, and cut infrastructure waste. The launch marks a strategic expansion that extends Clockwork’s Cloud capabilities-sub-microsecond visibility and cluster performance acceleration-into the AI and GPU domain, while adding stateful fault tolerance to prevent AI job crashes and slowdowns.

By transforming idle silicon into productive intelligence, Clockwork’s FleetIQ empowers enterprises, neoclouds, and hyperscalers to unlock greater performance from the same GPUs-delivering AI that is faster, more reliable, energy-efficient, and economically sustainable. This first-of-its-kind technology has attracted strong industry support. Led by existing investor NEA, Clockwork closed a new funding round at four times the valuation of its previous raise just two years ago. The round welcomed distinguished new backers, including Intel CEO Lip-Bu Tan, former Cisco CEO John Chambers, venture pioneer Carl Ledbetter, and e& Capital. Underscoring this momentum, the company appointed industry veteran Suresh Vasudevan as Chief Executive Officer and Joe Tarantino as Vice President of Worldwide Sales.

As AI moves from research to production, the bottleneck has shifted from raw compute to communication-between GPUs, across clusters, and across clouds. Most training jobs today run on NVIDIA or AMD GPUs with NVLink, InfiniBand and RoCE networks, but the challenge is universal: large GPU fleets must stay perfectly synchronized, and if even one link lags, the entire job pauses. In practice, this leads to what’s known as the “AI efficiency gap.” Despite massive investment, real-world GPU clusters achieve only ~30-55% of their theoretical performance, with further losses from disruptive faults and link failures occurring multiple times a week in large-scale systems. At scale, the cost of this inefficiency is staggering. Training today’s largest foundation models on a 100,000-GPU cluster-a $5-7 billion investment-can waste more than $2.25 billion in unused capacity. Closing this gap is now one of the defining challenges in scaling AI.

FleetIQ, Clockwork’s Software-Driven Fabric, directly addresses this challenge. Cofounded by Yilong Geng, Deepak Merugu and their PhD supervisor Professor Balaji Prabhakar, Clockwork’s foundational technology-software-based highly accurate Global Clock Sync and Dynamic Traffic Control-was developed at Stanford. FleetIQ leverages this foundation and delivers microsecond-level visibility across fleets and workloads to rapidly pinpoint slowdowns and failures. It adds stateful fault tolerance that keeps jobs running when links fail, avoiding costly AI job restarts; and boosts throughput with real-time, path-aware routing that eliminates contention and congestion. FleetIQ is hardware-agnostic, running across heterogeneous environments-NVIDIA, AMD, and custom accelerators; NCCL and RCCL; InfiniBand and Ethernet/RoCE-on-prem or in the cloud. The result: faster AI jobs and consistently high cluster utilization.

“AI has become the most distributed and demanding application in human history, and the next decade of AI infrastructure will belong to those who master communication between GPUs, between clusters, and clouds. Communication is the new Moore’s Law: the defining constraint to overcome for scale. At Clockwork, we are pioneering a Software-Driven Fabric (SDF)-an intelligent abstraction layer between workloads and infrastructure-that observes, predicts, and controls in real time, dynamically aligning application requirements and fabric behavior. This is not just a technical breakthrough. It enables organizations to achieve more with the same infrastructure. FleetIQ will make AI more economically viable for the decade ahead.”

– Suresh Vasudevan, CEO, Clockwork

“As AI infrastructure scales to tens of thousands of GPUs for training and inference, the bottleneck has shifted from compute to communication. With accelerators running in lockstep, a single link flap, congestion spike or straggler can stall progress and crater utilization. The operational priority is utilizing real-time fabric visibility for faster fault isolation and recovery to keep workloads moving instead of looping through costly restarts. And as Mixture of Experts (MoE) models with high rank expert parallelism proliferate, the all-to-all exchange intensifies, raising the bar even higher for GPU communication efficiency.”

– Dylan Patel, Founder, CEO, and Chief Analyst, SemiAnalysis

FleetIQ improves overall cluster efficiency by extending end-to-end visibility and control across both CPU-driven front-end and GPU-powered back-end networks. This enables teams to run training, inference and user-facing applications concurrently on the same cluster, improving economics, shortening time-to-market, and simplifying operations. FleetIQ works across Ethernet, InfiniBand, and RoCE, supports heterogeneous GPU environments, and requires no proprietary hardware.

Clockwork’s impact is already being felt by enterprises like Uber:

“At Uber, we tackle real-time logistics problems where every millisecond matters-latency spikes don’t just hurt customer experience, they directly impact driver retention and revenue. In our tests across a hybrid, multi-cloud environment, Clockwork delivered significant coverage and accuracy improvements over networking observability. Their unique innovation can greatly help Uber expedite the detection and fault-localization of networking issues: from hours to minutes, which will greatly improve service tail latency and prevent noisy neighbor impact.

We are in the process of rolling out Clockwork across Uber infrastructure, and look forward to experiencing their full capabilities at Uber’s scale. Clockwork’s software-driven fabric provides foundational observability for the hybrid, multi-cloud environment, helping us deliver what matters most: improved infrastructure utilization, enhanced resiliency, and ultimately, a better experience for the millions of people who rely on our platform every day.”

– Albert Greenberg, Chief Architect Officer, Uber

A vendor-neutral fabric for neocloud and enterprise AI at scale

As countries invest in sovereign, sustainable AI infrastructure, FleetIQ provides a hardware-agnostic control layer that raises cluster reliability and availability, delivering faster service for providers and better experiences for end users-making Clockwork a strategic design partner for neoclouds and enterprises.

“We have been working with Clockwork to evaluate their software-driven fabric on our AI infrastructure, and seeing meaningful improvements in reliability. This is exactly what our customers need when running large-scale AI workloads where any disruption can be costly. We like how this approach works across different network configurations without requiring hardware lock-in. As we continue to scale our infrastructure, solutions that focus on the communication layer-which is often a bottleneck-are becoming increasingly important for delivering the performance and reliability that our customers expect.”

– Danila Shtan, CTO, Nebius

“At NScale, we are building the foundation for AI at planetary scale-making it faster, more efficient, and more resilient for the world’s most ambitious organizations. To do that, we seek partners who share our vision for redefining what’s possible. Clockwork’s approach aligns perfectly with ours, and together we’re creating an AI infrastructure that is not only powerful and reliable, but ready to support the most demanding innovations of the future.”

– David Power, CTO, NScale

“At WhiteFiber, Clockwork helps us deploy GPU clusters faster and with greater consistency. Their observability and rapid localization of fabric issues not only reduce deployment times but also validate the reliability of our infrastructure, ensuring clients’ AI workloads run on clusters built for performance, resilience and scale.”

– Tom Sanfillippo CTO, White Fiber

Other European validation includes DCAI, operator of Gefion, Denmark’s flagship AI supercomputer:

“Our mission at DCAI is to remove barriers to high-performance AI infrastructure-not only to serve researchers, startups, and enterprises today, but also to build the sovereign foundations of tomorrow’s innovation economy. Gefion is a game-changing resource driving breakthroughs in quantum computing, drug discovery, advanced weather forecasting and beyond. To succeed, we must deliver resilience, reliability and efficiency at an unprecedented scale-performance once reserved for hyperscalers. Partnering with Clockwork enables us to operate Gefion seamlessly and reliably, even as workloads and demands increase.

The result is a compute-efficient, fault-tolerant infrastructure that researchers and industries can trust-lowering costs, eliminating wasted GPU cycles, and helping us deliver a sovereign AI capability second to none.”

– Dr. Nadia Carlsten, CEO, DCAI

Notable industry validation

“At Broadcom, our focus has always been on delivering Ethernet-centric infrastructure that scales AI with both performance and efficiency. Clockwork’s software-driven fabric adds an essential layer of agility and observability that enhances the power of our silicon. With proactive fleet monitoring and seamless failover, Clockwork enables platforms such as our Tomahawk 6 and Jericho4 to realize their full potential in flexibility, uptime, and AI performance. Together, we’re driving open, adaptable fabrics that allow enterprises to build AI infrastructure that is resilient, high-performing, and future-ready.”

– Ram Velaga, Senior Vice President and General Manager, Core Switching Group, Broadcom

“MI350X series systems with ROCm software and Pollara NICs provide a strong foundation for performance and reliability in AI training and inference. As deployments expand, ecosystem innovation, such as Clockwork’s software-driven approach, adds complementary capabilities that help ensure efficiency and consistency at scale.”

– Vamsi Boppana, SVP, AI, AMD

Clockwork’s launch of FleetIQ is paired with seasoned leadership to scale the new category. Suresh Vasudevan joins as CEO, a trusted technology leader with a track record of category creation and IPO-scale growth. He built Nimble Storage from $0 to $500M in revenue and an IPO, grew Sysdig from $5M to over $100M in ARR and into a category leader in container and cloud security, and served as Chief Product Officer at NetApp. “I am excited Suresh has joined us as CEO. He brings an exceptional combination of go-to-market leadership and product building experience required to scale entirely new categories, positioning Clockwork to enter its next phase of hypergrowth-delivering enterprise-grade, scalable infrastructure that meets the demands of the next generation of AI workloads,” said Balaji Prabhakar.

The company has also appointed Joe Tarantino as Vice President of Worldwide Sales-a proven sales leader instrumental in scaling Cohesity’s growth who, most recently, served at GMI Cloud, a top 10 NVIDIA neocloud partner-underscoring Clockwork’s strategic value. “While at GMI Cloud, I witnessed the explosive growth of enterprise AI and how quickly customers were consuming GPUs,” said Tarantino. “Clockwork helps them accelerate those investments by optimizing performance and resilience, and by taking AI initiatives from prototype to production faster.”

To learn more about Clockwork and the FleetIQ Platform, visit www.clockwork.io.

About Clockwork
Clockwork is the Software-Driven Fabric company for AI and high-performance workloads. Its FleetIQ intelligence layer addresses AI’s core scaling bottleneck: communication between GPUs, clusters, and clouds. Positioned between workloads and infrastructure, FleetIQ observes, predicts, and controls in real time-maximizing GPU utilization and accelerating job completion. Delivered in pure software across heterogeneous networks, it transforms communication from the weakest link into a unified control plane that classifies flows by intent, steers around hot paths, and paces traffic to protect priority work-unlocking dramatically higher utilization. By turning idle silicon into productive intelligence, Clockwork enables enterprises, neoclouds, and hyperscalers to do more with the same GPUs-making AI faster, reliable, efficient, and sustainable. Companies including Uber, Wells Fargo, DCAI, Nebius, Nscale, and White Fiber trust Clockwork to power their most demanding workloads. Learn more at www.clockwork.io.

Media Contact
Dana Trismen
clockwork@unshakablemarketinggroup.com

SOURCE: Clockwork

View the original press release on ACCESS Newswire

ANTWERPEN, BE / ACCESS Newswire / September 10, 2025 / OMP and Evonik Oxeno announce the successful go-live of a significant digital transformation milestone: the move of OMP’s Unison Planning^™ to the cloud across Evonik Oxeno’s key production sites in Marl and Antwerp. With this project going live, Oxeno elevates its planning capabilities into a new insight-driven, decision-centric planning era.

This is not a new beginning. It’s the next evolution of a platform that has been live and delivering real results since April 2021. Over the last four years, Evonik Oxeno has embraced decision-centric planning, calculating 30 to 50 scenarios per day and nearly 10,000 simulations since the launch. These scenarios allow teams to explore future possibilities and make informed, data-driven decisions across the company’s chemical value chain. The result is a supply chain that can respond to feedstock volatility, market shifts, or logistical risks while safeguarding business continuity and capturing opportunities.

The newly deployed version is a significant enhancement, built from the ground up based on four years of operational insight. It introduces a streamlined cloud environment, a purpose-built framework for continuous production, and more intelligent, low-friction workflows, making it easier and faster for planners to proactively optimize, simulate, compare, and act on complex scenarios. While the core approach remains the same, the new version lowers the barriers to advanced planning. It accelerates the path to insight, empowering planners to focus more on strategic decision-making.

“We didn’t reinvent how we work, we just made it easier,” said Frank Beißmann, Managing Director at Evonik Oxeno. “With this new version, we’ve taken everything we’ve learned and turned it into a faster, more intuitive, and even more powerful platform supporting confident, proactive decisions.”

OMP’s continued partnership with Evonik Oxeno underscores a shared commitment to innovation and operational excellence in the chemical industry.

“Oxeno’s forward-thinking approach is a benchmark for what decision-centric planning can achieve,” said Christian Wöllenstein, Senior Project Manager at OMP. “This upgrade reflects our shared vision of continuous improvement, one where supply chain planning is deeply intelligent, future-proof, and business-aligned.”

For a deeper dive into how Evonik Oxeno transformed its planning – including organizational changes, scenario-based decision-making, and sustainability gains beyond what’s covered here – explore the full story.

Contact Information

Christian Wöllenstein
Senior Project Manager at OMP
cwoellenstein@omp.com

SOURCE: OMP

Related Images

View the original press release on ACCESS Newswire

ADELAIDE, AU / ACCESS Newswire / September 10, 2025 / Barton Gold Holdings Limited (ASX:BGD)(FRA:BGD3)(OTCQB:BGDFF) (Barton or Company) advises that the attached presentation is due to be presented today at the Beaver Creek Precious Metals Summit.

A copy of this presentation can be accessed on the ASX website, the investor section of Barton’s website, or directly by clicking here.

Authorised by the Managing Director of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon Managing Director a.scanlon@bartongold.com.au +61 425 226 649

Jade Cook Company Secretary cosec@bartongold.com.au +61 8 9322 1587

About Barton Gold

Barton Gold is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000ozpa with 2.2Moz Au & 3.1Moz Ag JORC Mineral Resources (79.9Mt @ 0.87g/t Au), brownfield mines, and 100% ownership of the region’s only gold mill in the renowned Gawler Craton of South Australia.*

Competent Persons Statement & Previously Reported Information

The information in this announcement that relates to the historic Exploration Results and Mineral Resources as listed in the table below is based on, and fairly represents, information and supporting documentation prepared by the Competent Person whose name appears in the same row, who is an employee of or independent consultant to the Company and is a Member or Fellow of the Australasian Institute of Mining and Metallurgy (AusIMM), Australian Institute of Geoscientists (AIG) or a Recognised Professional Organisation (RPO). Each person named in the table below has sufficient experience which is relevant to the style of mineralisation and types of deposits under consideration and to the activity which he has undertaken to quality as a Competent Person as defined in the JORC Code 2012 (JORC).

Activity	Competent Person	Membership	Status
Tarcoola Mineral Resource (Stockpiles)	Dr Andrew Fowler (Consultant)	AusIMM	Member
Tarcoola Mineral Resource (Perseverance Mine)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Tarcoola Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tarcoola Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tunkillia Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Mineral Resource	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (above 215mRL)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (below 90mRL)	Mr Dale Sims	AusIMM / AIG	Fellow / Member
Wudinna Mineral Resource (Clarke Deposit)	Ms Justine Tracey	AusIMM	Member
Wudinna Mineral Resource (all other Deposits)	Mrs Christine Standing	AusIMM / AIG	Member / Member

The information relating to historic Exploration Results and Mineral Resources in this announcement is extracted from the Company’s Prospectus dated 14 May 2021 or as otherwise noted in this announcement, available from the Company’s website at www.bartongold.com.au or on the ASX website www.asx.com.au. The Company confirms that it is not aware of any new information or data that materially affects the Exploration Results and Mineral Resource information included in previous announcements and, in the case of estimates of Mineral Resources, that all material assumptions and technical parameters underpinning the estimates, and any production targets and forecast financial information derived from the production targets, continue to apply and have not materially changed. The Company confirms that the form and context in which the applicable Competent Persons’ findings are presented have not been materially modified from the previous announcements.

Cautionary Statement Regarding Forward-Looking Information

This document may contain forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “expect”, “target” and “intend” and statements than an event or result “may”, “will”, “should”, “would”, “could”, or “might” occur or be achieved and other similar expressions. Forward-looking information is subject to business, legal and economic risks and uncertainties and other factors that could cause actual results to differ materially from those contained in forward-looking statements. Such factors include, among other things, risks relating to property interests, the global economic climate, commodity prices, sovereign and legal risks, and environmental risks. Forward-looking statements are based upon estimates and opinions at the date the statements are made. Barton undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such dates or to update or keep current any of the information contained herein. Any estimates or projections as to events that may occur in the future (including projections of revenue, expense, net income and performance) are based upon the best judgment of Barton from information available as of the date of this document. There is no guarantee that any of these estimates or projections will be achieved. Actual results will vary from the projections and such variations may be material. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Any reliance placed by the reader on this document, or on any forward-looking statement contained in or referred to in this document will be solely at the readers own risk, and readers are cautioned not to place undue reliance on forward-looking statements due to the inherent uncertainty thereof.

View the original press release on ACCESS Newswire

ST. JOHN’S, NL / ACCESS Newswire / September 10, 2025 / Collision Clinic LTD, a trusted leader in automotive collision repair, has been recognized with the 2025-26 Consumer Choice Award in the Automobile Body Shop category for St. John’s. With a legacy spanning more than 45 years, the company has earned a reputation for quality repairs, ethical business practices, and exceptional customer service.

Since opening its flagship Topsail Road location in 1978, Collision Clinic has grown into a two-location operation serving St. John’s and surrounding areas. The company’s Torbay Road facility was added to meet growing demand, but the mission has remained the same: deliver precise, manufacturer-approved repairs, backed by transparent service and a commitment to safety.

A Legacy of Trust and Quality

Collision Clinic LTD was founded with the belief that customers deserve not only exceptional repair work but also complete peace of mind. Vehicles today are more technologically advanced than ever, and the company has continually adapted to meet those changes by investing heavily in advanced technology, and cutting-edge equipment. says the Collision Clinic team. Our technicians are highly trained in the industry, completing specialized ongoing education to keep pace with evolving vehicle designs and materials. From aluminum body repair to advanced driver-assistance systems (ADAS) calibration, the team is prepared to handle the complex requirements of today’s vehicles.

This dedication to ongoing improvement has afforded Collision Clinic to become both manufacturers certified, and customer preferred for all makes and models. Certification credentials are a mark of the company’s adherence to strict repair guidelines, ensuring repairs are completed correctly and safely.

Commitment to the Community

Beyond collision repair, Collision Clinic has a long-standing tradition of community involvement, supporting local causes and initiatives that make a positive impact in St. John’s. The company’s deep roots in the area have fostered strong relationships, and many customers have been returning for generations.

“We take the repair of our customers’ vehicles very seriously,” and it is important to provide them with the peace of mind that their vehicle is back on the road safely. Being able to serve our community for over 45 years is something we are deeply proud of.”

Our Nationwide Lifetime Guarantee has you covered for as long as you own your vehicle.

To learn more about Collision Clinic LTD. visit www.collisionclinic.com or CLICK HERE.

About Collision Clinic LTD
Collision Clinic LTD is a manufacturer-certified and customer-preferred collision repair facility with two locations: Topsail Rd and Torbay Rd. Established in 1978, the company is dedicated to restoring vehicles to manufacturer specifications through expert craftsmanship, advanced technology, and premium customer service.

About Consumer Choice Award
Since 1987, Consumer Choice Award has been recognizing and promoting business excellence across North America. Through a rigorous selection process, only the most outstanding businesses in each category earn this prestigious recognition. Learn more at www.ccaward.com.

Contact Information
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire